GH News and Press, Guardant Health Inc. From 11/06/23

Q3 revenue increased 22% year over year driven by clinical volume growth of 35% Raises 2023 revenue guidance to $553 to 556 million Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary ...

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

Guardant Health Inc. (GH) is expected to report $-0.93 for Q3 2023

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences: Jefferies 14 th Annual Global Healthcare Conference in London, UK Presentation on Thursday, November 16 at 9:00 a.m. Greenwich ...

Seamless ordering and receipt of genomic test results directly in patient records streamlines clinician access to precision medicine tools Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Flatiron Health , a leading healthtech company dedicated to expand...

2023-10-29 17:28:12 ET More on Guardant Health, Natera, etc. Natera: Cash Burn Remains A Concern Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Mar...

Study results suggest Guardant Reveal TM circulating tumor DNA blood test may help clinicians decide to pursue more or less aggressive post-surgical chemotherapy regimens PEGASUS is first clinical utility trial for tissue-free detection of minimal residual disease Guardant...

2023-10-17 09:15:48 ET Palm Beach, FL – October 17, 2023 – FinancialNewsMedia.com News Commentary – Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight infections. The US mult...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will report financial results for the third quarter of 2023 after market close on Monday, November 6, 2023. Company management will be webcasting a corresponding conference call beginning at 1:30...

Not intended for distribution to U.S. newswire services or for dissemination in the U.S. RED DEER, AB / ACCESSWIRE / October 16, 2023 / Gamehost Inc. ('Gamehost', the 'Company') (TSX:GH) Gamehost has declared a cash dividend for the month of October 2023 of $0.03 (CDN) per common share, whi...